Sanofi copies Shell with €2bn triple trancher, but widens in secondary
Sanofi, the French pharmaceutical company, priced a €2bn three tranche bond on Monday — a large slice of the day’s activity as issuers kept up strong supply in a heavy-feeling European corporate bond market.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article: